Methods of treating fatty liver disease
US9556155B2 · kind B2 · utility
3Cited by
48References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2014 |
| Grant date | Jan 31, 2017 |
| Priority date | — |
| Expiry date | Apr 8, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides methods for treating fatty liver disease and associated conditions by inhibiting the synthesis of glucosphingolipids, as exemplified by the use of glucosylceramide synthase substrate analogs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.